Vitamin D and VDR gene polymorphism (FokI) in epithelial ovarian cancer in Indian population

Journal of Ovarian Research

Volumn 6, Issue 1, 2013, Pages

  Mohapatra, Sudhesna ^a   Saxena, Alpana ^a   Gandhi, Gauri ^a   Koner, Bidhan Chandra ^a   Ray, Prakash Chandra ^a  

^a MAULANA AZAD MEDICAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

FOK1 PROTEIN; RESTRICTION ENDONUCLEASE; UNCLASSIFIED DRUG; VITAMIN D; VITAMIN D RECEPTOR;

ADULT; ARTICLE; CANCER RISK; CHEMILUMINESCENCE IMMUNOASSAY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC PREDISPOSITION; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; INDIA; OVARY CARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

EID: 84878005237     PISSN: None     EISSN: 17572215     Source Type: Journal    
DOI: 10.1186/1757-2215-6-37     Document Type: Article

References (31)

1. Global cancer statistics, 2002. Parkin DM, Bray F, Ferlay J, Pisani P, CA Cancer J Clin 2005 55 2 74 108 10.3322/canjclin.55.2.74 15761078
2. National Institute for Clinical Excellence (NICE), Paclitaxel, pegylated liposomal doxorubicin hydrochloride and topotecan for second-line or subsequent treatment of advanced ovarian cancer Technology appraisal 91. 2005 http://guidance.nice.org.uk/TA91/Guidance/pdf/English
3. Lower vitamin-D production from solar ultraviolet-B irradiance may explain some differences in cancer survival rates. Grant WB, J Nat Med Assoc 2006 98 3 357 364
4. Diagnostic circulating vitamin D concentration and risk of colorectal cancer in European populations: a nested case-control study. Jenab M, Bueno-De-Mesquita HB, Ferrari P, Van Duijnhoven FJ, Norat T, Pischon T, Jansen EH, Slimani N, Byrnes G, Rinaldi S, Tjønneland A, Olsen A, Overvad K, Boutron-Ruault MC, Clavel-Chapelon F, Morois S, Kaaks R, Linseisen J, Boeing H, Bergmann MM, Trichopoulou A, Misirli G, Trichopoulos D, Berrino F, Vineis P, Panico S, Palli D, Tumino R, Ros M, Van Gils CH, BMJ 2010 340 5500 10.1136/bmj.b5500 20093284
5. Circulating vitamin D and risk of epithelial ovarian cancer. Arslan AA, Clendenen TV, Koenig KL, Hultdin J, Enquist K, Agren A, Lukanova A, Sjodin H, Zeleniuch-Jacquotte A, Shore R, Hallmans G, Toniolo P, Lundin E, J Oncol 2009 2009 672492 19727412
6. Plasma 25-hydroxyvitamin D and 1,25-Dihydroxyvitamin D and risk of incident ovarian cancer. Tworoger SS, Lee IM, Buring JE, Rosner B, Hollis BW, Hankinson SE, Cancer Epidemiol Biomarkers Prev 2007 16 783 788 10.1158/1055-9965.EPI-06-0981 17416771
7. Genetics and biology of vitamin D receptor polymorphisms. Uitterlinden AG, Fang Y, Van Meurs JB, Pols HA, Van Leeuwen JP, Gene 2004 338 2 143 156 10.1016/j.gene.2004.05.014 15315818
8. Review and meta-analysis on vitamin D receptor polymorphisms and cancer risk. Raimondi S, Johansson H, Maisonneuve P, Gandini S, Carcinogenesis 2009 30 7 1170 1180 10.1093/carcin/bgp103 19403841
9. The relevance of vitamin D receptor (VDR) gene polymorphisms for cancer: a review of the literature. Köstner K, Denzer N, Müller CS, Klein R, Tilgen W, Reichrath J, Anticancer Res 2009 29 9 3511 3536 19667145
10. Vitamin D receptor gene polymorphisms and epithelial ovarian cancer risk. Lurie G, Wilkens LR, Thompson PJ, McDuffie KE, Carney ME, Terada KY, Goodman MT, Cancer Epidemiol Biomarkers Prev 2007 16 12 2566 2571 10.1158/1055-9965.EPI- 07-0753 18086759
11. Vitamin D receptor polymorphisms and risk of epithelial ovarian cancer. Clendenen TV, Arslan AA, Koenig KL, Enquist K, Wirgin I, Agren A, Lukanova A, Sjodin H, Zeleniuch-Jacquotte A, Shore RE, Hallmans G, Toniolo P, Lundin E, Cancer Lett 2008 260 1-2 209 215 18079052
12. Polymorphisms in the vitamin D receptor and risk of ovarian cancer in four studies. Tworoger SS, Gates MA, Lee IM, Buring JE, Titus-Ernstoff L, Cramer D, Hankinson SE, Cancer Res 2009 69 5 1885 1891 10.1158/0008-5472.CAN-08-3515 19223536
13. Vitamin D receptor rs2228570 polymorphism and invasive ovarian carcinoma risk: Pooled analysis in five studies within the Ovarian Cancer Association Consortium. Lurie G, Wilkens LR, Thompson PJ, Carney ME, Palmieri RT, Pharoah PD, Song H, Hogdall E, Kjaer SK, Dicioccio RA, McGuire V, Whittemore AS, Gayther SA, Gentry-Maharaj A, Menon U, Ramus SJ, Goodman MT, Int J Cancer 2010 128 4 936 943
14. The VDR start codon polymorphism (Fok-I) and bone mineral density in premenopausal American Black and White women. Harris SS, Eccleshall TR, Gross C, DawsonHughes B, Feldman D, J Bone Miner Res 1997 12 1043 1048 10.1359/jbmr.1997.12.7.1043 9200003
15. The synergy factor: a statistic to measure interactions in complex diseases. Cortina-Borja M, Smith AD, Combarros O, Lehmann DJ, BMC Res Notes 2009 2 105 10.1186/1756-0500-2-105 19527493
16. Calculated ultraviolet exposure levels for a healthy vitamin D status. Webb AR, Engelsen O, Photochem Photobiol 2006 82 1697 1703 16958558
17. An estimate of premature cancer mortality in the U.S. due to inadequate doses of solar ultraviolet-B radiation. Grant WB, Cancer 2002 94 1867 1875 10.1002/cncr.10427 11920550
18. Sunlight, vitamin D, and ovarian cancer mortality rates in U.S. women. Lefkowitz ES, Garland CF, Int J Epidemiol 1994 23 1133 1136 10.1093/ije/23.6. 1133 7721513
19. Sunlight and mortality from breast, ovarian, colon, prostate, and non-melanoma skin cancer: a composite death certificate based case-control study. Freedman D, Dosemeci M, McGlynn K, Occup Environ Med 2002 59 257 262 10.1136/oem.59.4.257 11934953
20. Does solar ultraviolet irradiation affect cancer mortality rates in China? Grant WB, Asian Pacific J Cancer Prev 2007 8 236 242
21. Role of Ultraviolet B Irradiance and Vitamin D in Prevention of Ovarian Cancer. Mohr SB, Gorham ED, Grant WB, Garland FC, Am J Prev Med 2006 31 6 512 514 10.1016/j.amepre.2006.08.018 17169713
22. High prevalence of low dietary calcium, high phytate consumption, and vitamin D deficiency in healthy south Indians. Harinarayan CV, Ramalakshmi T, Prasad UV, Sudhakar D, Srinivasarao PV, Sarma KV, Kumar EG, Am J Clin Nutr 2007 85 1062 1067 17413106
23. Presence of 25(OH)D deficiency in rural north Indian village despite abundant sunshine. Goswami R, Kochupillai N, Gupta N, Goswami D, Singh N, Dudha A, J Assoc Physicians India 2008 56 755 757 19263699
24. Estrogens (E2) regulate expression and response of 1,25-dihydroxyvitamin D3 receptors in bone cells: changes with aging and hormone deprivation. Duque G, El Abdaimi K, Macoritto M, Miller MM, Kremer R, Biochem Biophys Res Commun 2002 299 3 446 454 10.1016/S0006-291X(02)02657-8 12445821
25. Functionally relevant polymorphisms in the human nuclear vitamin D receptor gene. Whitfield GK, Remus LS, Jurutka PW, Zitzer H, Oza AK, Dang HT, Haussler CA, Galligan MA, Thatcher ML, Encinas Dominguez C, Haussler MR, Mol Cell Endocrinol 2001 177 145 159 10.1016/S0303-7207(01)00406-3 11377830
26. Molecular epidemiology of vitamin D receptor gene variants. Zmuda JM, Cauley JA, Ferrell RE, Epidemiol Rev 2000 22 2 203 217 10.1093/oxfordjournals. epirev.a018033 11218372
27. A vitamin D receptor gene polymorphism in the translation initiation codon: effect on protein activity and relation to bone mineral density in Japanese women. Arai H, Miyamoto K, Taketani Y, Yamamoto H, Iemori Y, Morita K, Tonai T, Nishisho T, Mori S, Takeda E, J Bone Miner Res 1997 12 915 921 10.1359/jbmr.1997.12.6.915 9169350
28. Functional significance of vitamin D receptor FokI polymorphism in human breast cancer cells. Alimirah F, Peng X, Murillo G, Mehta RG, PLoS One 2011 6 1 16024 10.1371/journal.pone.0016024 21283672
29. Curcumin: a novel nutritionally derived ligand of the vitamin D receptor with implications for colon cancer chemoprevention. Bartik L, Whitfield GK, Kaczmarska M, Lowmiller CL, Moffet EW, Furmick JK, Hernandez Z, Haussler CA, Haussler MR, Jurutka PW, J Nutr Biochem 2010 21 12 1153 1161 10.1016/j.jnutbio.2009.09.012 20153625
30. Vitamin D receptor ligands, adenomatous polyposis coli, and the vitamin D receptor FokI polymorphism collectively modulate beta-catenin activity in colon cancer cells. Egan JB, Thompson PA, Vitanov MV, Bartik L, Jacobs ET, Haussler MR, Gerner EW, Jurutka PW, Mol Carcinog 2010 49 4 337 352 20043299
31. A novel protein complex that interacts with the vitamin D3 receptor in a ligand-dependent manner and enhances vitamin D receptor transactivation in a cell-free system. Rachez C, Suldan Z, Ward J, Genes Dev 1998 12 1787 1800 10.1101/gad.12.12.1787 9637681